Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|September 14, 2024
Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid LeukemiaMalia E Leifheit, Gunnar Johnson, Timothy M Kuzel, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 1, 2004
Agreement between prostate cancer patients and their clinicians about utilities and attribute importanceArthur S Elstein, Gretchen B Chapman, Joan S Chmiel, et al.
Journal of the American Academy of Dermatology|October 21, 2006
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoidesMadeleine Duvic, Matthew L Sherman, Gary S Wood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2016
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established CancerDonye Dominguez, Cong Ye, Zhe Geng, et al.
Oncogene|December 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic targetMarina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, et al.
International Journal of Molecular Sciences|December 11, 2025
IL-15 Complexes Combined with PD-1 Blockade Affect Immune Cell Distribution, Localization, and Immune Signatures in Regressing Versus Non-Regressing Metastatic Breast TumorsJosef W Goldufsky, Anjelica F Reyes, Allie A Heller, et al.
Annals of Surgical Oncology|June 10, 2016
National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality MeasuresChristina A Minami, Jeffrey D Wayne, Anthony D Yang, et al.
JAMA Oncology|June 1, 2016
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical TrialSaby George, Robert J Motzer, Hans J Hammers, et al.
The Journal of Clinical Investigation|April 3, 2025
4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor responseJihae Ahn, Ping Xie, Siqi Chen, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Pageof 12